Description: SpectraCure AB (publ) engages in the development of cancer treatment system. It develops Q-PRO, a laser device; and IDOSE software with interstitial photodynamic therapy system for the treatment of prostate cancer. The company was incorporated in 2003 and is based in Lund, Sweden.
Home Page: www.spectracure.com
Gasverksgatan 1
Lund,
222 29
Sweden
Phone:
46 46 16 20 70
Officers
| Name | Title |
|---|---|
| Dr. Masoud Khayyami Ph.D. | Interim CEO & Director |
| Mr. Henrik Ljung | Chief Financial Officer |
| Dr. Johannes Swartling Ph.D. | Chief Technology Officer |
| Ms. Mirjam Johansson | Administrative Manager |
| Ms. Kristina Holst | Head of Clinical Affairs |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.6217 |
| Price-to-Sales TTM: | 34.2325 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 13 |